You must be a subscriber to see the full results of your search.
Please log in or subscribe below if you are not already a subscriber.
The Daily News subscribers get full access to more than
13
million names and addresses along with powerful search and download features.
Get the business leads you need with powerful searches of public records and notices.
Download listings into your spreadsheet or database.
Learn more about our services
| Search again
Editorial Results (free)
1.
Collierville Man Awarded $140M in Androgel Lawsuit -
Saturday, October 14, 2017
A federal jury in Chicago, Illinois, has awarded a Collierville resident $140 million in punitive damages against pharmaceutical company AbbVie Inc., the plaintiff and maker of Androgel, a topical men’s testosterone replacement product the jury found caused the man to have a heart attack.
2.
Collierville Man Awarded $140M in Androgel Lawsuit -
Wednesday, October 11, 2017
A federal jury in Chicago, Illinois, has awarded a Collierville resident $140 million in punitive damages against pharmaceutical company AbbVie Inc., the plaintiff and maker of Androgel, a topical men’s testosterone replacement product the jury found caused the man to have a heart attack.
3.
Drugmakers Pledge Restraint, But Prices Will Still Soar -
Tuesday, February 28, 2017
TRENTON, N.J. (AP) – Several big drugmakers are trying to quell the ongoing furor over high drug prices by revealing more information about their pricing and even pledging to keep a lid on increases.
4.
Limits on Overseas Mergers Prompt Renewed Debate -
Wednesday, September 24, 2014
WASHINGTON (AP) – The Obama administration's decision to curb the ability of U.S. corporations to skirt taxes by merging with foreign companies kicked off an immediate election-season debate over when and how to tackle the nation's complex corporate tax code.
5.
Walgreen Turns Down Inversion to Cut Tax Bill -
Thursday, August 7, 2014
Walgreen plans to keep its roots firmly planted in the United States, saying it will no longer pursue an overseas reorganization that would have trimmed its U.S. taxes but drew political scorn.
The nation's largest drugstore chain – which bills itself as "America's premier pharmacy" – said Wednesday that it will buy the remaining stake in Swiss health and beauty retailer Alliance Boots that it does not already own.
6.
AbbVie, Shire Agree on $55 Billion Combination -
Monday, July 21, 2014
The drugmaker AbbVie has reached a deal worth roughly $55 billion to combine with British counterpart Shire and become the latest U.S. company to seek an overseas haven from tax rates back home.
The companies said Friday they will create a new company that is incorporated on the British island of Jersey, where Shire currently is incorporated. But the new company will be controlled by shareholders of North Chicago, Illinois-based AbbVie, who will own about 75 percent of the new company's stock.